Showing results (2501-2510 of 5,969) with videos related to
Sort By:
Pageof 597
Endocrine|August 31, 2012
A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulationsRoberto Vita, Giovanna Saraceno, Francesco Trimarchi, et al.Endocrine|May 3, 2023
Denosumab for osteoporosis in patients with primary hyperparathyroidism and mild-to-moderate renal insufficiencySofia Gronskaya, Zhanna Belaya, Liudmila Rozhinskaya, et al.Endocrine|May 6, 2023
Quantitative analysis of dual-phase enhanced CT in cervical lymph node metastasis of papillary thyroid carcinoma: a comparative study along with pathological manifestationsChang Shao, Yanyan Shu, Peiying Wei, et al.Endocrine|March 27, 2021
Assessing potential impact of 2015 American Thyroid Association guidelines on community standard practice for I-131 treatment of low-risk differentiated thyroid cancer: case study of JordanMalik E Juweid, Nidal J Rabadi, Mark Tulchinsky, et al.Endocrine|August 9, 2020
Comparison of postprandial 90th-minute plasma glucose level with 60th- and 120th-minute levels in patients with gestational diabetes: a prospective cohort studyOzge Sever, Kemal Sarsmaz, A S Ozgu-Erdinc, et al.Endocrine|August 10, 2020
Cause-specific mortality after diagnosis of thyroid cancer: a large population-based studyBinbin Du, Fang Wang, Leiming Wu, et al.Endocrine|July 19, 2020
The 2039 A/G FSH receptor gene polymorphism influences glucose metabolism in healthy menRossella Cannarella, Nicolò Musso, Rosita A Condorelli, et al.Endocrine|July 22, 2020
Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancerHelton Estrela Ramos, Fabio Hecht, Amandine Berdelou, et al.Endocrine|April 2, 2021
Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control studyMaría Fernández-Argüeso, Eider Pascual-Corrales, Nuria Bengoa Rojano, et al.Pageof 597